![XiuGui Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
XiuGui Chen
Hoofd Techniek/Wetenschap/O&O bij TYK Medicines, Inc.
Profiel
XiuGui Chen is currently the Senior VP-Clinical & Registration Department at TYK Medicines, Inc. Previously, he worked as a Medical Director at Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
He earned a doctorate degree from Shanghai University.
Actieve functies van XiuGui Chen
Bedrijven | Functie | Begin |
---|---|---|
TYK Medicines, Inc.
![]() TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Hoofd Techniek/Wetenschap/O&O | 01-08-2018 |
Eerdere bekende functies van XiuGui Chen
Bedrijven | Functie | Einde |
---|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
![]() Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van XiuGui Chen
Shanghai University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
![]() Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
TYK Medicines, Inc.
![]() TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Health Technology |